- Home
- WBUY vs SNSE Comparison
WBUY vs SNSE Comparison
Compare WBUY & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBUY
- SNSE
- Stock Information
- Founded
- WBUY 2019
- SNSE 2005
- Country
- WBUY Singapore
- SNSE United States
- Employees
- WBUY N/A
- SNSE N/A
- Industry
- WBUY
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- WBUY
- SNSE Health Care
- Exchange
- WBUY Nasdaq
- SNSE Nasdaq
- Market Cap
- WBUY 13.7M
- SNSE 12.3M
- IPO Year
- WBUY 2023
- SNSE 2021
- Fundamental
- Price
- WBUY $0.18
- SNSE $0.45
- Analyst Decision
- WBUY
- SNSE Strong Buy
- Analyst Count
- WBUY 0
- SNSE 3
- Target Price
- WBUY N/A
- SNSE $4.33
- AVG Volume (30 Days)
- WBUY 31.4M
- SNSE 330.7K
- Earning Date
- WBUY 02-15-2025
- SNSE 11-14-2024
- Dividend Yield
- WBUY N/A
- SNSE N/A
- EPS Growth
- WBUY N/A
- SNSE N/A
- EPS
- WBUY N/A
- SNSE N/A
- Revenue
- WBUY $65,440,760.00
- SNSE N/A
- Revenue This Year
- WBUY $42.04
- SNSE N/A
- Revenue Next Year
- WBUY $37.84
- SNSE N/A
- P/E Ratio
- WBUY N/A
- SNSE N/A
- Revenue Growth
- WBUY 21.33
- SNSE N/A
- 52 Week Low
- WBUY $0.11
- SNSE $0.38
- 52 Week High
- WBUY $0.82
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- WBUY 48.88
- SNSE 47.08
- Support Level
- WBUY $0.17
- SNSE $0.41
- Resistance Level
- WBUY $0.41
- SNSE $0.50
- Average True Range (ATR)
- WBUY 0.03
- SNSE 0.05
- MACD
- WBUY -0.00
- SNSE -0.00
- Stochastic Oscillator
- WBUY 2.53
- SNSE 34.09
About WBUY WEBUY GLOBAL LTD.
Webuy Global Ltd is an emerging Southeast Asian (SEA) community-oriented e-commerce retailer (Community e-Commerce Retailor) with a focus on grocery and travel. Community e-commerce is a deepened extension form of e-commerce, where social media users with mutual interest and like-minded behavior are connected, forming a community group within a network through an online medium. Its mission is to make social shopping a new lifestyle for consumers and to empower consumers' purchases with an efficient cost-saving purchasing model. The company is also engaged in selling packaged tours to its customers. The majority of revenue is derived from the sales of groceries through its online platform. Its geographic areas are Singapore, Indonesia, and Malaysia.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.